The DCPH Paradox: Analysts Bullish But Forecast -2.61% Fall
July 06, 2018 at 08:08 AM EDT
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Deciphera Pharmaceuticals Inc (DCPH). The average 12-month price target for DCPH averaging the work of 4 analysts reveals an average price target of $41.00/share..